MEDICAPS
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Medi-Caps Ltd Says Medi-Caps Business Park Project Has Been Completed
June 16 (Reuters) - Medi-Caps Ltd MEDI.BO:
MEDI-CAPS BUSINESS PARK PROJECT HAS BEEN COMPLETED
Source text: ID:nBSE9nbHW3
Further company coverage: MEDI.BO
(([email protected];;))
June 16 (Reuters) - Medi-Caps Ltd MEDI.BO:
MEDI-CAPS BUSINESS PARK PROJECT HAS BEEN COMPLETED
Source text: ID:nBSE9nbHW3
Further company coverage: MEDI.BO
(([email protected];;))
Medi-Caps Says USFDA Issues Form 483 To Medgel After Inspection
Feb 24 (Reuters) - Medi-Caps Ltd MEDI.BO:
MEDI-CAPS LTD - USFDA CONDUCTED GMP INSPECTION OF MEDGEL FACILITY
MEDI-CAPS LTD - USFDA ISSUES FORM 483 TO MEDGEL AFTER INSPECTION
MEDI-CAPS LTD - NO DATA INTEGRITY OBSERVATIONS IN USFDA INSPECTION OF MEDGEL
Source text: ID:nBSE4Rf10n
Further company coverage: MEDI.BO
(([email protected];;))
Feb 24 (Reuters) - Medi-Caps Ltd MEDI.BO:
MEDI-CAPS LTD - USFDA CONDUCTED GMP INSPECTION OF MEDGEL FACILITY
MEDI-CAPS LTD - USFDA ISSUES FORM 483 TO MEDGEL AFTER INSPECTION
MEDI-CAPS LTD - NO DATA INTEGRITY OBSERVATIONS IN USFDA INSPECTION OF MEDGEL
Source text: ID:nBSE4Rf10n
Further company coverage: MEDI.BO
(([email protected];;))
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Medi-Caps do?
Founded in 1983, Medi-Caps Limited is a leading manufacturer of empty hard gelatin capsules in India, offering a product range comprising six sizes with a strong market presence.
Who are the competitors of Medi-Caps?
Medi-Caps major competitors are Daikaffil Chemicals, TCM, Auro Impex & Chem., Polylink Polymers, Seya Industries, MCON Rasayan India, TECIL Chem & Hydro. Market Cap of Medi-Caps is ₹37 Crs. While the median market cap of its peers are ₹42 Crs.
Is Medi-Caps financially stable compared to its competitors?
Medi-Caps seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Medi-Caps pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Medi-Caps latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Medi-Caps allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Medi-Caps balance sheet?
Balance sheet of Medi-Caps is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Medi-Caps improving?
The profit is oscillating. The profit of Medi-Caps is -₹5.64 Crs for TTM, -₹0.57 Crs for Mar 2025 and -₹2.24 Crs for Mar 2024.
Is the debt of Medi-Caps increasing or decreasing?
Yes, The net debt of Medi-Caps is increasing. Latest net debt of Medi-Caps is -₹0.09 Crs as of Sep-25. This is greater than Mar-25 when it was -₹0.82 Crs.
Is Medi-Caps stock expensive?
Medi-Caps is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Medi-Caps is 113, while 3 year average PE is 53.87. Also latest EV/EBITDA of Medi-Caps is 0.0 while 3yr average is 27.68.
Has the share price of Medi-Caps grown faster than its competition?
Medi-Caps has given lower returns compared to its competitors. Medi-Caps has grown at ~-24.95% over the last 2yrs while peers have grown at a median rate of -22.88%
Is the promoter bullish about Medi-Caps?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Medi-Caps is 50.76% and last quarter promoter holding is 50.77%
Are mutual funds buying/selling Medi-Caps?
There is Insufficient data to gauge this.
